Driving Life Sciences Innovation with Industrial AI
Explore how 3D UNIVERSES, powered by industrial AI, help you predict outcomes, reduce risks and deliver higher-quality therapies faster than ever before.
In an age driven by relentless progress, life sciences and healthcare companies must find ways to innovate faster, reduce risks and deliver safer, higher-quality therapies. This is where Dassault Systèmes’ 3D UNIVERSES come in. Powered by the 3DEXPERIENCE® platform, 3D UNIVERSES connect virtual twins of the patient, product, process and plant at next-level speed and scale. They allow companies to activate decades of dormant intellectual property (IP), converting it into actionable insights that spark new forms of innovation — such as new therapies — while driving business model innovation and even transforming the organization as a whole.
With IP-driven project lifecycle management (IP-PLM), companies can protect and govern innovation while making smarter decisions across the entire product lifecycle. Combined with artificial intelligence (AI) and virtual twins, 3D UNIVERSES turn this intelligence into a continuous advantage, helping organizations navigate complexity, accelerate development and bring better treatments to patients faster — with greater reliability.
The Business Impact of AI in Biopharma and MedTech
Biopharma and MedTech companies are increasingly adopting AI to innovate faster, make smarter decisions and scale operations efficiently. According to the McKinsey Global Institute, AI could generate $60 to $110 billion in annual value for pharmaceutical and medical products companies, primarily by boosting productivity. More specifically, Deloitte reports that nearly 90% of this value comes from research and development (R&D), manufacturing and supply chain, and commercial operations, highlighting AI as a critical driver of growth and competitiveness.
By streamlining discovery and enhancing clinical trials and manufacturing, AI drives measurable business impact — unlocking more personalized patient solutions and realizing the potential outlined by these studies. These improvements help companies reduce costs, shorten time to market and deliver better outcomes for both patients and the business.
We stand on the threshold of a new era in artificial intelligence that promises to achieve an unprecedented level of ability. A new generation of agents will acquire superhuman capabilities by learning predominantly from experience.
The V+R Power of Industrial AI
The greatest value of 3D UNIVERSES comes from industrial AI — a game-changing intelligence grounded in scientific, regulatory and operational expertise, purpose-built for biopharma and MedTech companies. Unlike consumer AI, which focuses on generating text or images, industrial AI works with complex real-world data — from simulations, sensors, manufacturing systems and product usage — to connect digital intelligence with physical processes.
Imagine this: Virtual twins of your patients, products, processes and plants are centralized in a single environment. The virtual and real aspects of 3D UNIVERSES provide a unified representation of the life sciences and healthcare landscape, revealing answers to questions you’ve been asking for years: “How will a new ingredient change the properties of my existing formulations?” and “Will this new compound improve patient outcomes or enable a personalized treatment?”
Data: The Foundation of Industrial AI in Life Sciences
Applying industrial AI starts with data-driven knowledge and know-how. In life sciences, many processes still rely on paper, so it’s essential to understand where your data is, its type and the problems you want to solve. Dassault Systèmes helps companies structure and connect this data on the 3DEXPERIENCE platform — a knowledge and know-how factory that turns raw data into context-rich information. By linking information across R&D, manufacturing and commercial domains, virtual twin experiences reveal organizational knowledge, while industrial AI amplifies this knowledge into actionable insights, empowering teams to drive smarter, more confident decisions.
From Data to Insight: Virtual Twins and Industrial AI
To start the AI agent from a foundation, AI developers might use a "world model" simulation. The “world model” lets an AI model make predictions, test those predictions in the real world, and then use the reward signals to make the model more realistic.
Today, Dassault Systèmes helps over 14,000 life sciences companies innovate by connecting real-world data with virtual twin experiences across patients, products, processes and plants. Here’s how that works in practice.
- Patient: Simulate populations and organs to improve clinical trials and medical device testing
- Product: Design safer, more effective drugs and devices by linking patient insights with R&D data
- Process: Optimize manufacturing steps and ensure quality through risk-based, proactive approaches
- Plant: Scale production efficiently and adapt facilities to meet global or personalized medicine demands
By harnessing industrial AI and modeling virtual twins of patients, therapies, processes and plants within 3D UNIVERSES, companies can simulate outcomes before implementation, identify risks before they occur and deliver higher-quality treatments — improving patient and physician experiences worldwide.
Unlocking Value from Intellectual Property
3D UNIVERSES help companies innovate at scale and speed. By combining industrial AI, knowledge and know-how, models and best practices, they securely elevate IP across the product lifecycle into an IP-driven PLM system. This approach transforms raw data into actionable insights, connects relationships across systems and builds models and ontologies that guide smarter decision-making.
Core benefits:
- Navigate complexity: Connect information across R&D, manufacturing and commercial operations with unprecedented speed and scale
- Explore new possibilities: Leverage virtual worlds, what-if scenarios and AI simulations to accelerate innovation
- Achieve 360° synthesis: Gain a holistic, AI-driven view of products, processes and IP — empowering teams and improving outcomes
By combining the power of industrial AI, virtual twins and IP-driven PLM, Dassault Systèmes’ 3D UNIVERSES help life sciences companies predict outcomes, reduce risks and deliver better therapies faster, all on a unified platform that spans the full product lifecycle.
3D UNIVERSES: The Next Frontier in Life Sciences
As industries reshape in real time, there’s no better moment to transform your organization with 3D UNIVERSES. Harness the power of industrial AI grounded in decades of scientific knowledge and real-world experience to generate actionable answers you can trust.
Combined with IP-driven PLM and virtual twins, this groundbreaking intelligence models your organization end to end, empowering teams to speed up innovation, identify risk early and deliver therapies patients can trust.
The New Standard for Life Sciences Innovation
Faster breakthroughs, more predictable outcomes and superior experiences for those delivering and receiving care worldwide. Ready to lead the change?